|
December 2025
Idiopathic intracranial hypertension (IIH) has been very rarely reported in patients treated with mesalazine. Following a recent review, warnings for IIH are being added to the product information for all mesalazine products.
It's easy to report
Report a suspected adverse drug reaction online or download the Yellow Card app
Thank you,
The Medicines and Healthcare products Regulatory Agency
|